VIRP Share Price

Open 152.00 Change Price %
High 154.45 1 Day -1.60 -1.05
Low 150.10 1 Week -4.20 -2.72
Close 150.40 1 Month 16.35 12.20
Volume 6977 1 Year -1.45 -0.95
52 Week High 197.95
52 Week Low 127.00
VIRP Important Levels
Resistance 2 154.43
Resistance 1 152.77
Pivot 151.65
Support 1 148.03
Support 2 146.37
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
AVQ 0.47 0.00%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
BRS 12.00 0.00%
EPA France Top Gainers Stocks
MLGEO 0.03 50.00%
MLDIG 1.20 33.33%
RX 5.26 30.20%
RX 5.26 30.20%
RX 5.26 30.20%
ALALO 0.10 25.00%
DBG 6.33 21.97%
MLVER 8.00 18.52%
APAM 33.78 15.72%
APAM 33.78 15.72%
EPA France Top Losers Stocks
OXI 0.06 -14.29%
OXI 0.06 -14.29%
MLAAE 4.50 -10.00%
ALDV 0.09 -10.00%
CIB 0.09 -10.00%
CIB 0.09 -10.00%
CIB 0.09 -10.00%
CIB 0.09 -10.00%
MLGES 2.30 -8.00%
ASY 35.05 -5.27%

Virbac (EPA: VIRP)

VIRP Technical Analysis 1.5
As on 23rd May 2017 VIRP Share Price closed @ 150.40 and we RECOMMEND Sell for LONG-TERM with Stoploss of 159.31 & Buy for SHORT-TERM with Stoploss of 148.56 we also expect STOCK to react on Following IMPORTANT LEVELS.
VIRP Target for May
1st Target up-side 154.5
2nd Target up-side 161.47
3rd Target up-side 168.44
1st Target down-side 134.6
2nd Target down-side 127.63
3rd Target down-side 120.66
VIRP Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website
VIRP Address
13e rue LID - BP 27
Carros, 06511
Phone: 33 4 92 08 71 00
Fax: 33 4 92 08 71 65
VIRP Latest News
Virbac SA (ENXTPA:VIRP) Earnings & Valuation in Perspective   Union Trade Journal   - 23rd May 17
Virbac SA (ENXTPA:VIRP): A look inside the numbers   TCT   - 22nd May 17
KCADC: New facility solidifies KC as the 'epicenter of animal health'   Kansas City Business Journal   - 19th Apr 17
BRIEF-Virbac Q1 sales fall to 199.7 million euros   Reuters   - 12th Apr 17
Virbac launches clinical diets   VetSurgeon News   - 31st Mar 17
Virbac gives Vet Aquadent a fresh look   VetSurgeon News (press release)   - 03rd Feb 17
Virbac launches phenobarbital-based canine epilepsy treatment   VetSurgeon News (press release)   - 02nd Feb 17
Virbac : annual sales growth of 4.5%, at constant exchange rates   GlobeNewswire (press release)   - 17th Jan 17
BRIEF-Virbac says FDA lifts warning letter for St. Louis production facility   Reuters   - 16th Dec 16
Sequent Aims to Lure Buyers in $30 Billion Veterinary Market   Bloomberg   - 30th Jul 15
Interactive Technical Analysis Chart Virbac ( VIRP EPA France )
Java support must be enabled in order to display FnCharts.
You can download Java from
Your Comments and Response on Virbac
VIRP Business Profile
Virbac SA develops, manufactures, and sells vaccines and medicines to prevent and treat pathologies for companion and food-producing animals in France, the rest of Europe, North America, Latin America, Africa, the Middle East, Asia, and the Pacific region. The company’s products comprise Bovidec to treat bovine viral diarrhea; Browse plus, a nutritional supplement; CaniLeish to protect against canine leishmaniosi; Deltanil for use in cattle and sheep as a topical application; Effi pro for flea and tick infestations in dogs and cats; Epi-Otic, a ear cleanser for dogs and cats; Flukazole C, a internal parasiticide in cattle and sheep for benzimidazole-sensitive worms; and Fortius, a injectable antibiotic. Its products also include Cydectine, a moxidectin-based parasiticide; Iverhart, a chewable tablet for use in dogs to prevent canine heartworm, roundworms, hookworms, and tapeworms; Luminal to treat epilepsy in dogs; Maxflor for respiratory diseases of bacterial origin in cattle and pigs; Milteforan, a miltefosine-based oral treatment; and Multibio for digestive, respiratory, and genitourinary diseases. In addition, the company offers Multimin, a trace element injectable supplement; Nutri plus gel, an oral paste-based food supplement; Ostovet, a food supplement for cattle; Penclox for mastitis in dairy cattle; Prodose, an anthelmintic; Pulmodox for respiratory diseases in pigs and poultry; Rabigen mono, a monovalent and multi-dose rabies vaccine; Rabigen SAG2, an oral rabies vaccine; Super Mastidol to prevent and treat mastitis in dairy cattle; Suprelorin for temporary infertility in male dogs; Virbamec, a ivermectin-based parasiticide; Vet complex, a specialised petfood; Veterin for swine, poultry, and salmonids; Vetflurane, a isoflurane-based general anaesthetic; Vimeral, a food supplement; and Zoletil, a multi-species general anaesthetic. Further, it provides contract manufacturing services. Virbac SA was founded in 1968 and is headquartered in Carros, France.